Biogen MA Inc. v. EMD Serono, Inc.

Where the novelty of a method of administration rests wholly on the novelty of the composition administered, which in turn rests on a source limitation, the anticipation analysis for the method claim necessarily reaches the same conclusion as for the composition.

Written by

A language model, from how the MPEP uses this case rather than from the opinion.

Confidence

high — self-reported, not calibrated against a measured error rate

Human review

Not reviewed by a person

Read the opinion before relying on this in a filing. How these are made · Report an error